Brief: Ataibeckley Announces Successful End-Of-Phase 2 Meeting For Bpl-003 In Treatment-Resistant Depression
03/03/2026 12:28
March 3 (Reuters) - AtaiBeckley Inc ATAI.O: ATAIBECKLEY ANNOUNCES SUCCESSFUL END-OF-PHASE 2 MEETING FOR BPL-003 IN TREATMENT-RESISTANT DEPRESSION ATAIBECKLEY INC: PHASE 3 PROGRAM INITIATION REMAINS ON TRACK FOR Q2 2026 ATAIBECKLEY INC - ALIGNED WITH FDA ON PHASE 3 PROGRAM FOR BPL-003 Source text: ID:nGNX6ZPxTd Further company coverage: ATAI.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on AtaiBeckley
See all newsFDA to hold public hearing on psychedelic drugs as Trump-driven push gathers pace
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:28 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM